National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium. Read more about National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium.
Deep Learning to Simulate Contrast-enhanced Breast MRI of Invasive Breast Cancer. Read more about Deep Learning to Simulate Contrast-enhanced Breast MRI of Invasive Breast Cancer.
Deep Learning to Simulate Contrast-enhanced Breast MRI of Invasive Breast Cancer. Read more about Deep Learning to Simulate Contrast-enhanced Breast MRI of Invasive Breast Cancer.
Deep Learning to Predict Neonatal and Infant Brain Age from Myelination on Brain MRI Scans. Read more about Deep Learning to Predict Neonatal and Infant Brain Age from Myelination on Brain MRI Scans.
Back to the Future: A Mesh Balloon for Wide-necked Brain Aneurysm Endovascular Treatment. Read more about Back to the Future: A Mesh Balloon for Wide-necked Brain Aneurysm Endovascular Treatment.
Comparing Mammographic Density Assessed by Digital Breast Tomosynthesis or Digital Mammography: The Breast Cancer Surveillance Consortium. Read more about Comparing Mammographic Density Assessed by Digital Breast Tomosynthesis or Digital Mammography: The Breast Cancer Surveillance Consortium.
An Image Quality-informed Framework for CT Characterization. Read more about An Image Quality-informed Framework for CT Characterization.
Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Read more about Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women. Read more about Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women.
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Read more about Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.